T1	Treatment 33 78	granulocyte colony-stimulating factor therapy
T2	Treatment 312 334	high-dose chemotherapy
T3	Treatment 347 400	autologous peripheral blood stem cell transplantation
T4	Treatment 495 532	granulocyte colony-stimulating factor
T5	Treatment 770 783	primary PBSCT
T6	Treatment 1068 1073	PBSCT
T7	Treatment 1213 1218	G-CSF
T8	Treatment 1259 1265	PBSCT)
T9	Treatment 1280 1293	control group
T10	Treatment 1343 1535	high-dose regimens without total body irradiation consisted of the MCVAC regimen using ranimustine (MCNU, 450 mg/m2), cytosine arabinoside (16 g/m2), etoposide (1.6 g/m2), and cyclophosphamide
T11	Treatment 1579 1609	Hi-MEC regimen using melphalan
T12	Treatment 1623 1632	etoposide
T13	Treatment 1649 1662	carboplatinum
